EFPIA - NEWSLETTER

EFPIA Newsletter 12 July 2018

New EBE-EFPIA study demonstrates benefits of personalised medicine for patients, society and healthcare systems

The European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) released today the outcome of the evidence-based analysis on personalised medicine carried out by Charles River Associates on their behalf.

Personalised medicine is defined as “a medical model using characterisation of individuals’ phenotypes and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention”.

News

25 June 2018 25062018 Apply now for the Health Collaboration Awards 2018

Submit a project by 21 September 2018

Videos

A lifetime of breakthroughs

We were born to end patients’ suffering. To extend life and improve its quality. And right now, after decades of tireless medical innovation, we still won’t rest.

Fighting Cancer, For a Brighter Tomorrow

With over 1800 medicines in development we won’t rest until everyone affected by cancer sees a brighter tomorrow.

Events

27 SEP 2018

28052018 ITCC-P4 International Workshop: Improving pediatric oncology drug development... Amsterdam, The Netherlands

The overarching goal is to streamline and improve the development of new oncology drugs for children and adolescents...

Learn more →

20 NOV 2018

War On Cancer Europe 2018 London

The technological revolution and the future of patient engagement - A conference organised by The Economist

Learn more →

We published

2018: The pharmaceutical industry in figures 28 June 2018 (Publications)

The Pharmaceutical Industry: a key asset to scientific and medical progress

IMI PARADIGM Study

Survey to Find Out Stakeholders’ Needs and Expectations for Patient Engagement in the Medicines... 12 July 2018 (IMI Paradigm)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶